PMS-1 exploratory Investigator Initiated clinical trial
- Conditions
- atients scheduled to undergo surgery under general anesthesia
- Registration Number
- JPRN-jRCT2052200025
- Lead Sponsor
- akai Kunihiro
- Brief Summary
The PS measured by the Pain Management System PMS-1 correlated with the amount of change in the NRS and VAS measurements, which are commonly used to measure and evaluate pain in daily practice, and could be used as an indicator to monitor the efficacy of analgesics for postoperative pain. In addition, it was confirmed that patients scheduled to undergo surgery under general anesthesia were the target patients for whom the pain performance evaluation of the device concerned could be appropriately conducted.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
(1) Patients 20 years or older at the time of consent acquisition
(2) Patients scheduled to undergo surgery under general anesthesia
(3) Patients with no apparent cognitive impairment
(4) Gender: Any
(5) Patients who have their own free written consent
(1) Patients with known neurological disorders such as epilepsy, or patients with a history
(2) Patients taking narcotic analgesics
(3) Patients with a history of cerebral infarction and cerebral hemorrhage
(4) Patients with a history of other organic brain diseases
(5) Patients who have already been diagnosed with chronic pain
(6) Patients with cardiac pacemakers or electronic implants
(7) Patients with severe visual impairment
(8) Women who may be pregnant
(9) Patients who are judged by the investigator or the investigator to be inappropriate to participate in this clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method